drugset / Trial / NCT03915561

Effect of Intravenous Dynastat on Postoperative Sore Throat

NCT03915561

Phase 2 Unknown 140 enrolled Buddhist Tzu Chi General Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

A postoperative sore throat (POST) after tracheal intubation is one of the most common postoperative problems causing dissatisfaction to participants, including sore throat, dry throat, cough, sputum, hoarseness and even dysphagia. Both nonpharmacological and pharmacological measures have been attempted to alleviate the incidence and severity of POST with variable success. Airway inflammation may be important in the pathogenesis of these symptoms in intubated participants but however, there was still no study to investigate the effect of cyclooxygenase-2 (COX-2) for the prevention of POST. So, the investigators' study will be the first one to investigate if perioperatively intravenous (IV) Dynastat injection can be used as a new indication for POST prevention.

Timeline

Start
2019-03-01
Primary completion
2020-03-01
Completion
2020-11-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Parecoxib Small molecule 40 mg Intravenous

Indications